KOE · 340450.KQ
GC Genome Corporation
₩9,100+₩520 (+6.06%)
GC Genome Corporation’s quoted price sits in the upper half of its reported 52-week range, 13.17% below the high.
Loading market information…
KOE · 100120.KQ · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Vieworks Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 23.35% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Vieworks Co., Ltd.’s forward annual dividend is ₩600 per share, paid annual. The forward yield is 2.24% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Vieworks Co., Ltd.’s next earnings report is currently expected on Nov 11, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Vieworks Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Vieworks Co., Ltd. is dedicated to the development, manufacturing, and sale of comprehensive imaging systems and solutions. The company provides X-ray detectors alongside image processing technologies utilized across numerous fields, including general and veterinary radiography systems, dental and surgical C-arm systems, radiography and fluoroscopy setups, and industrial inspection instruments. Beyond its X-ray offerings, Vieworks also produces industrial-grade cameras and specialized bio-imaging systems, which encompass in vivo imaging solutions under the VISQUE brand. Founded in 1999, the organization was formerly known as Raysis Co., Ltd. before officially changing its name to Vieworks Co., Ltd. in November 2006. The company maintains its headquarters in Anyang-si, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:46 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Feb 11, 2025 |
| ₩1,005 |
| ₩59.7B-3.63% vs estimate |
| Q3 2024 | Nov 6, 2024 | ₩140 | ₩48.4B-17.23% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩9,100+₩520 (+6.06%)
GC Genome Corporation’s quoted price sits in the upper half of its reported 52-week range, 13.17% below the high.
₩5,260-₩90 (-1.68%)
EASY BIO,Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.55% below the high.
₩10,510-₩80 (-0.76%)
JW Lifescience Corporation’s quoted price sits in the lower half of its reported 52-week range, 32.54% below the high.
₩21,150-₩650 (-2.98%)
Ilsung Is Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.82% below the high.
₩5,100-₩60 (-1.16%)
Dongwha Pharm.Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.54% below the high.
₩14,480+₩80 (+0.56%)
Shinhung Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 12.08% below the high.
₩5,020-₩40 (-0.79%)
DongBang Medical’s quoted price sits in the lower half of its reported 52-week range, 48.03% below the high.
₩5,090-₩110 (-2.12%)
Osang Healthcare Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 65.14% below the high.
